Oura Pushes for New FDA Category for Wearable Health Alerts

Oura, the company behind the widely used smart ring, is pushing for changes in how the U.S. Food and Drug Administration regulates wearable health devices. Currently, the FDA divides these devices into two categories. General wellness products face minimal oversight and are typically marketed for fitness tracking, sleep monitoring, or other lifestyle purposes. Medical devices, on the other hand, must undergo a lengthy approval process demonstrating safety and effectiveness before they can provide health-related guidance.

Oura is advocating for the creation of a third classification, which the company refers to as “digital health screeners.” This classification would allow wearable devices to notify users of potential health abnormalities without delivering a formal medical diagnosis. The company argues that such a category would provide consumers with valuable health insights while avoiding the lengthy medical-device approval process that can take years and require substantial clinical data.

The proposal reflects the growing capabilities of wearable devices. Modern smart rings and watches can measure heart rate, sleep patterns, respiratory rate, and even oxygen saturation. Some devices are already capable of detecting irregular heart rhythms or changes in sleep that may signal health issues. Oura’s push highlights a tension between innovation in consumer technology and the need for regulatory oversight to ensure that health information is accurate and safe.

Observers say the creation of a “digital health screener” category could provide a clear framework for wearable companies to offer health insights without being treated as full medical devices. Such a framework could accelerate the adoption of advanced health monitoring tools and allow consumers to access information that might encourage earlier medical intervention.

Joanne M. Frederick, CEO of Government Market Strategies, emphasized the potential benefits of wearables while raising privacy concerns. “The Oura Ring is a powerful feedback tool that gives individuals insight into their own ‘operating system’ each day. As a consistent subscriber since 2020, I’ve seen how access to real-time health data can increase awareness and personal accountability. From a policy standpoint, empowering people to better understand their own health is a positive development. Where things become more complicated is when government sponsorship of a device potentially intersects with access to personal health data. Any public-sector partnership involving wearable technology must draw a bright line around individual data ownership and privacy. The goal should be to create cultures and structures that strengthen personal agency — not systems that centralize sensitive health information.”

The potential risks of less oversight has raised concerns. Devices could provide inaccurate information that may either alarm users unnecessarily or give them a false sense of security. Additionally, health data generated by consumer devices often falls outside the protections that apply to traditional medical records, raising questions about privacy and data security.

Regulators have not indicated whether they plan to adopt a separate category for devices like Oura’s ring. The FDA has previously issued guidance for consumer devices that provide health-related insights but stops short of approving them as medical devices unless they are intended to diagnose or treat specific conditions. Oura’s proposal would require the agency to reconsider these distinctions and define criteria for accuracy, user safety, and data protection within a new regulatory pathway.

The conversation around wearable regulation comes at a time of rapid growth in the health-tech sector. Analysts say the demand for digital health tools is increasing as consumers become more proactive about monitoring their health. Wearables are now being used in studies for cardiovascular health, sleep disorders, and chronic disease management, demonstrating both their potential benefits and the importance of clear oversight.

The outcome of Oura’s lobbying efforts could have broader implications for the wearable industry. If a new category were established, other companies could follow, potentially transforming how consumer devices deliver health information. Observers note that regulators will need to balance innovation with patient safety, considering both the opportunities and risks of providing health alerts outside traditional medical channels.

As wearable technology continues to advance, the question of how devices should be regulated will remain central to discussions about digital health. For now, Oura is leading the push to create a framework that would allow devices to offer potentially life-saving insights without triggering the full medical-device approval process, setting the stage for a debate about the future of health monitoring in the digital age.